← Leaderboards
Rajasingh Johnson
University Of Illinois At Chicago
$1,936,650
Attributed
$1,936,650
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $382.5K · FY2009–22$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,936,650 · 2
By mechanism
R01$1,504,900 · 1
R21$431,750 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Subhash C Pandey$28,170,363
- Arnon Lavie$5,954,044
- Ah-Ng Tony Kong$19,827,201
- Yogen Saunthararajah$12,927,987
- Dawood Darbar$15,920,976
Others in their field
Top investigators on “Messenger Rna”
- Jeffrey P Krischer · University Of South Florida$206,732,287
- David Heimbrook · Leidos Biomedical Research, Inc.$96,474,613
- Henry F Chambers · Duke University$47,759,573
- Vance G Fowler · Duke University$46,487,462
- Barton F Haynes · Duke University$43,472,529
- Bradley F Boeve · Mayo Clinic Rochester$42,990,413
Research focus
Messenger RnaTransplantationGenesIn VivoScid MiceStem Cell TherapyEndothelial CellsGenerationsHeart FailureIn VitroMyocardial IschemiaRegenerative MedicineSourceStem CellsCellsCardiacCardiac MyocytesCell TherapyAffectChronicAutologousInduced Pluripotent Stem CellMolecularAmerican
Grant awards (7)
scaRNA Modified Induced Pluripotent Stem Cell-Derived Cardiomyocytes or Exosomes Therapy for Chronic Ischemic Cardiomyopathy Patients$369,497
R01 · FY2022 · HL · contact PI
scaRNA Modified Induced Pluripotent Stem Cell-Derived Cardiomyocytes or Exosomes Therapy for Chronic Ischemic Cardiomyopathy Patients$372,903
R01 · FY2021 · HL · contact PI
scaRNA Modified Induced Pluripotent Stem Cell-Derived Cardiomyocytes or Exosomes Therapy for Chronic Ischemic Cardiomyopathy Patients$380,000
R01 · FY2020 · HL · contact PI
scaRNA Modified Induced Pluripotent Stem Cell-Derived Cardiomyocytes or Exosomes Therapy for Chronic Ischemic Cardiomyopathy Patients$382,500
R01 · FY2019 · HL · contact PI
Epigenetic modification of endothelial progenitor cells into multipotent cells$138,369
R21 · FY2010 · HL · contact PI
Epigenetic modification of endothelial progenitor cells into multipotent cells$97,131
R21 · FY2010 · HL · contact PI
Epigenetic modification of endothelial progenitor cells into multipotent cells$196,250
R21 · FY2009 · HL · contact PI